Screener
Lexicon Pharmaceuticals LXRX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net (loss) income | $(31,775) | $3,252 | $(32,818) | $(22,043) |
| Net (loss) income per common share, basic | $(0.07) | $0.01 | $(0.08) | $(0.06) |
| Net (loss) income per common share, diluted | $(0.07) | $0.01 | $(0.08) | $(0.06) |
| Weighted average common shares outstanding, basic | 437,653 | 363,294 | 419,050 | 362,687 |
| Weighted average common shares outstanding, diluted | 437,653 | 363,570 | 419,050 | 362,687 |
| Other comprehensive (loss) income: | ||||
| Unrealized loss on investments | (74) | (39) | (234) | (133) |
| Comprehensive (loss) income | $(31,849) | $3,213 | $(33,052) | $(22,176) |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent?
- Lexicon Pharmaceuticals (LXRX) reported comprehensive income (loss), net of tax, attributable to parent of -$31.85M in Q2 2026.
- How has Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent decreased by 1091.3% year-over-year, from $3.21M to -$31.85M.
- What is the long-term trend for Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent has grown at a -12.9% compound annual growth rate (CAGR), from -$87.76M to -$50.43M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- A comprehensive measure of financial performance that includes net income plus other gains and losses that bypass the traditional income statement. It provides a broader view of the company's total change in equity from non-owner sources.
Ask your AI about Lexicon Pharmaceuticals's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude